Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi D Sabag

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Basic and Clinical Physiology and Pharmacology|November 16, 2005
Connexins in hearing loss: a comprehensive overviewAdi D Sabag, Orit Dagan, Karen B Avraham
Cold Spring Harbor Perspectives in Medicine|February 9, 2012
Semaphorins in angiogenesis and tumor progressionGera Neufeld, Adi D Sabag, Noa Rabinovicz, et al.
Journal of Autoimmunity|December 5, 2022
CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosusNasren Eiza, Adi D Sabag, Ofra Kessler, et al.
Plos One|September 1, 2012
Semaphorin-3D and semaphorin-3E inhibit the development of tumors from glioblastoma cells implanted in the cortex of the brainAdi D Sabag, Julia Bode, Dorit Fink, et al.
The Journal of Biological Chemistry|July 26, 2006
The structural context of disease-causing mutations in gap junctionsSarel J Fleishman, Adi D Sabag, Eran Ophir, et al.
Cell Death & Disease|January 19, 2023
Plexin-A2 enables the proliferation and the development of tumors from glioblastoma derived cellsShira Toledano, Adi D Sabag, Neta Ilan, et al.
Journal of Cell Science|October 23, 2014
The role of the plexin-A2 receptor in Sema3A and Sema3B signal transductionAdi D Sabag, Tatyana Smolkin, Yelena Mumblat, et al.
Frontiers in Immunology|April 20, 2018
Semaphorin3A: A Potential Therapeutic Tool for Lupus NephritisJacob Bejar, Ofra Kessler, Adi D Sabag, et al.
Frontiers in Pediatrics|December 12, 2022
Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patientsZufit Hexner-Erlichman, Maria Veiga-da-Cunha, Yoav Zehavi, et al.
International Journal of Molecular Sciences|November 27, 2025
Semaphorin3A Rewires CD4<sup>+</sup> T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid ArthritisRaeda Mubariki, Nasren Eiza, Adi D Sabag, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Basic and Clinical Physiology and Pharmacology|November 16, 2005
Connexins in hearing loss: a comprehensive overviewAdi D Sabag, Orit Dagan, Karen B Avraham
Cold Spring Harbor Perspectives in Medicine|February 9, 2012
Semaphorins in angiogenesis and tumor progressionGera Neufeld, Adi D Sabag, Noa Rabinovicz, et al.
Journal of Autoimmunity|December 5, 2022
CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosusNasren Eiza, Adi D Sabag, Ofra Kessler, et al.
Plos One|September 1, 2012
Semaphorin-3D and semaphorin-3E inhibit the development of tumors from glioblastoma cells implanted in the cortex of the brainAdi D Sabag, Julia Bode, Dorit Fink, et al.
The Journal of Biological Chemistry|July 26, 2006
The structural context of disease-causing mutations in gap junctionsSarel J Fleishman, Adi D Sabag, Eran Ophir, et al.
Cell Death & Disease|January 19, 2023
Plexin-A2 enables the proliferation and the development of tumors from glioblastoma derived cellsShira Toledano, Adi D Sabag, Neta Ilan, et al.
Journal of Cell Science|October 23, 2014
The role of the plexin-A2 receptor in Sema3A and Sema3B signal transductionAdi D Sabag, Tatyana Smolkin, Yelena Mumblat, et al.
Frontiers in Immunology|April 20, 2018
Semaphorin3A: A Potential Therapeutic Tool for Lupus NephritisJacob Bejar, Ofra Kessler, Adi D Sabag, et al.
Frontiers in Pediatrics|December 12, 2022
Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patientsZufit Hexner-Erlichman, Maria Veiga-da-Cunha, Yoav Zehavi, et al.
International Journal of Molecular Sciences|November 27, 2025
Semaphorin3A Rewires CD4<sup>+</sup> T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid ArthritisRaeda Mubariki, Nasren Eiza, Adi D Sabag, et al.
Pageof 1